MolMed NGR-hTNF four studies accepted for presentation at ASCO 2013

May 27, 2016 | Author: social_molmed | Category: Types, Reviews


Description

MolMed S.p.A. (MLM.MI) today announced that four studies on its investigational therapeutics NGR-hTNF and TK have been a...

Comments

SUPPORT DOCURI